Results for tag: "Irritable Bowel Syndrome"

The Irritable Bowel Syndrome (IBS) market is a subset of the Gastroenterology market. IBS is a chronic disorder of the digestive system that affects the large intestine. Symptoms include abdominal pain, bloating, constipation, and diarrhea. Treatment options include dietary changes, medications, and lifestyle modifications. The IBS market is expected to grow due to increasing prevalence of the disorder, rising awareness of IBS, and the availability of new treatments. Additionally, the increasing demand for better diagnosis and treatment of IBS is expected to drive the market. Some companies in the IBS market include Allergan, AstraZeneca, GlaxoSmithKline, Ironwood Pharmaceuticals, Novartis, Pfizer, Salix Pharmaceuticals, Shire, Sucampo Pharmaceuticals, and Takeda Pharmaceuticals. Show Less Read more